• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结构洞察新冠病毒刺突糖蛋白、M 和 PL 与氰病毒-N 的结合:蛋白-蛋白相互作用、动力学模拟和自由能计算。

Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M and PL of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations.

机构信息

Centre for Algal Biotechnology, Mangosuthu University of Technology, P.O. Box 12363, Durban 4026, South Africa.

Bioinformatics Facility, Department of Botany, University of North Bengal, Siliguri 734013, India.

出版信息

Molecules. 2021 Aug 24;26(17):5114. doi: 10.3390/molecules26175114.

DOI:10.3390/molecules26175114
PMID:34500548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8434238/
Abstract

The emergence of COVID-19 continues to pose severe threats to global public health. The pandemic has infected over 171 million people and claimed more than 3.5 million lives to date. We investigated the binding potential of antiviral cyanobacterial proteins including cyanovirin-N, scytovirin and phycocyanin with fundamental proteins involved in attachment and replication of SARS-CoV-2. Cyanovirin-N displayed the highest binding energy scores (-16.8 ± 0.02 kcal/mol, -12.3 ± 0.03 kcal/mol and -13.4 ± 0.02 kcal/mol, respectively) with the spike protein, the main protease (M) and the papainlike protease (PL) of SARS-CoV-2. Cyanovirin-N was observed to interact with the crucial residues involved in the attachment of the human ACE2 receptor. Analysis of the binding affinities calculated employing the molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) approach revealed that all forms of energy, except the polar solvation energy, favourably contributed to the interactions of cyanovirin-N with the viral proteins. With particular emphasis on cyanovirin-N, the current work presents evidence for the potential inhibition of SARS-CoV-2 by cyanobacterial proteins, and offers the opportunity for in vitro and in vivo experiments to deploy the cyanobacterial proteins as valuable therapeutics against COVID-19.

摘要

新冠疫情的持续蔓延,对全球公共卫生构成严重威胁。截至目前,该疫情已感染超过 1.71 亿人,并导致超过 350 万人死亡。我们研究了抗病毒蓝藻蛋白(包括 、 和藻蓝蛋白)与新冠病毒 2 型(SARS-CoV-2)附着和复制相关基本蛋白的结合潜力。 与 SARS-CoV-2 的刺突蛋白、主蛋白酶(M)和木瓜蛋白酶样蛋白酶(PL)的结合能评分最高(分别为-16.8±0.02 kcal/mol、-12.3±0.03 kcal/mol 和-13.4±0.02 kcal/mol)。 与参与人类 ACE2 受体附着的关键残基相互作用。使用分子力学-泊松-玻尔兹曼表面面积(MM-PBSA)方法计算的结合亲和力分析表明,除极性溶剂化能外,所有形式的能量都有利于 与病毒蛋白的相互作用。特别强调了 ,目前的工作为蓝藻蛋白可能抑制 SARS-CoV-2 提供了证据,并为体外和体内实验提供了机会,以将蓝藻蛋白作为治疗 COVID-19 的有价值的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b0a28ad9bf2f/molecules-26-05114-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/816023102d1e/molecules-26-05114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/a9a5d1eb278a/molecules-26-05114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b61c39048040/molecules-26-05114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/d1a1fe026a60/molecules-26-05114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/466473c61d0f/molecules-26-05114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/f9c1a7ff6da7/molecules-26-05114-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b93cdd04cf6f/molecules-26-05114-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b0a28ad9bf2f/molecules-26-05114-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/816023102d1e/molecules-26-05114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/a9a5d1eb278a/molecules-26-05114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b61c39048040/molecules-26-05114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/d1a1fe026a60/molecules-26-05114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/466473c61d0f/molecules-26-05114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/f9c1a7ff6da7/molecules-26-05114-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b93cdd04cf6f/molecules-26-05114-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a4b/8434238/b0a28ad9bf2f/molecules-26-05114-g008.jpg

相似文献

1
Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M and PL of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations.结构洞察新冠病毒刺突糖蛋白、M 和 PL 与氰病毒-N 的结合:蛋白-蛋白相互作用、动力学模拟和自由能计算。
Molecules. 2021 Aug 24;26(17):5114. doi: 10.3390/molecules26175114.
2
Blue Biotechnology: Computational Screening of Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition.蓝色生物技术:基于计算的膜海松二萜类化合物对 SARS-CoV-2 主蛋白酶抑制作用的筛选
Mar Drugs. 2021 Jul 13;19(7):391. doi: 10.3390/md19070391.
3
Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.通过分子对接、 MM-PBSA 结合能计算和分子动力学模拟鉴定潜在的植物源性 SARS-CoV-2 病毒蛋白酶抑制剂。
Mol Divers. 2021 Aug;25(3):1963-1977. doi: 10.1007/s11030-021-10211-9. Epub 2021 Apr 15.
4
Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics.计算发现 SARS-CoV-2 刺突/ACE2 和 M 的双重潜在抑制剂:3D 药效团、基于对接的虚拟筛选、量子力学和分子动力学。
Eur Biophys J. 2024 Aug;53(5-6):277-298. doi: 10.1007/s00249-024-01713-z. Epub 2024 Jun 21.
5
Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.筛选一些具有活性的植物化学成分,以鉴定有希望抑制 SARS-CoV-2 靶点的抑制剂。
Curr Drug Discov Technol. 2024;21(3):73-89. doi: 10.2174/0115701638243222230920051050.
6
Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations.通过分子动力学和结合自由能模拟探索 PF-07321332 SARS-CoV-2 蛋白酶抑制剂的结合机制。
Int J Mol Sci. 2021 Aug 24;22(17):9124. doi: 10.3390/ijms22179124.
7
Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.分子对接和动力学研究鉴定 SARS-CoV-2 的 3-糜蛋白酶样蛋白酶的潜在抑制剂:批准的嘧啶酮类药物用于 COVID-19 治疗的再利用。
Molecules. 2021 Dec 9;26(24):7458. doi: 10.3390/molecules26247458.
8
Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.小分子与 SARS-CoV-2 木瓜蛋白酶样蛋白酶的相互作用:使用酶抑制测定法进行的体外验证和体外验证蛋白酶活性抑制的计算研究。
J Mol Graph Model. 2021 May;104:107851. doi: 10.1016/j.jmgm.2021.107851. Epub 2021 Jan 26.
9
Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study.金属结合美替唑酮;针对 SARS-CoV-2 的预防和治疗的新型药物,分子对接研究。
Int J Mol Sci. 2021 Mar 15;22(6):2977. doi: 10.3390/ijms22062977.
10
Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches.通过多种计算和生化方法发现的天然和合成产物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)木瓜样蛋白酶的蛋白酶和去泛素酶活性的破坏作用
Int J Biol Macromol. 2024 Oct;277(Pt 4):134476. doi: 10.1016/j.ijbiomac.2024.134476. Epub 2024 Aug 5.

引用本文的文献

1
Mannose-specific plant and microbial lectins as antiviral agents: A review.甘露糖特异性植物和微生物凝集素作为抗病毒药物:综述。
Glycoconj J. 2024 Feb;41(1):1-33. doi: 10.1007/s10719-023-10142-7. Epub 2024 Jan 20.
2
The Antiviral Potential of Algal Lectins.藻类凝集素的抗病毒潜力。
Mar Drugs. 2023 Sep 28;21(10):515. doi: 10.3390/md21100515.
3
Cyanometabolites: molecules with immense antiviral potential.氰基代谢物:具有巨大抗病毒潜力的分子。

本文引用的文献

1
PRODIGY: A Contact-based Predictor of Binding Affinity in Protein-protein Complexes.PRODIGY:一种基于接触的蛋白质-蛋白质复合物结合亲和力预测器。
Bio Protoc. 2017 Feb 5;7(3):e2124. doi: 10.21769/BioProtoc.2124.
2
Mechanism of inhibition of SARS-CoV-2 M by peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.通过量子力学/分子力学模拟解释肽基迈克尔受体对SARS-CoV-2 M的抑制机制以及设计具有可调化学反应性的新衍生物
Chem Sci. 2020 Nov 27;12(4):1433-1444. doi: 10.1039/d0sc06195f.
3
Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production.
Arch Microbiol. 2023 Apr 3;205(5):164. doi: 10.1007/s00203-023-03514-y.
4
The nanomolar affinity of C-phycocyanin from virtual screening of microalgal bioactive as potential ACE2 inhibitor for COVID-19 therapy.微藻生物活性物质虚拟筛选出的C-藻蓝蛋白作为治疗COVID-19的潜在ACE2抑制剂的纳摩尔亲和力。
J King Saud Univ Sci. 2023 Apr;35(3):102533. doi: 10.1016/j.jksus.2022.102533. Epub 2023 Jan 5.
5
Engineering recombinantly expressed lectin-based antiviral agents.工程重组表达基于凝集素的抗病毒剂。
Front Cell Infect Microbiol. 2022 Sep 23;12:990875. doi: 10.3389/fcimb.2022.990875. eCollection 2022.
6
Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone.靶向严重急性呼吸综合征冠状病毒2木瓜蛋白酶样蛋白酶的潜在抑制剂:一石二鸟。
Front Chem. 2022 Feb 23;10:822785. doi: 10.3389/fchem.2022.822785. eCollection 2022.
7
Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses.具有不同特异性的豆科植物凝集素作为潜在的糖探针用于致病包膜病毒。
Cells. 2022 Jan 20;11(3):339. doi: 10.3390/cells11030339.
严重急性呼吸综合征冠状病毒2刺突蛋白聚糖在病毒感染和抗体产生中的作用
Front Mol Biosci. 2021 Apr 13;8:629873. doi: 10.3389/fmolb.2021.629873. eCollection 2021.
4
Antiviral Cyanometabolites-A Review.抗病毒蓝细菌代谢产物——综述
Biomolecules. 2021 Mar 22;11(3):474. doi: 10.3390/biom11030474.
5
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.组织蛋白酶L在SARS-CoV-2感染人类和人源化小鼠过程中起关键作用,是新药研发的一个有前景的靶点。
Signal Transduct Target Ther. 2021 Mar 27;6(1):134. doi: 10.1038/s41392-021-00558-8.
6
COVID-19 effects on shared-biking in New York, Boston, and Chicago.新冠疫情对纽约、波士顿和芝加哥共享单车的影响。
Transp Res Interdiscip Perspect. 2021 Mar;9:100282. doi: 10.1016/j.trip.2020.100282. Epub 2020 Dec 15.
7
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.弗林蛋白酶切割 SARS-CoV-2 刺突促进但不是感染和细胞-细胞融合所必需的。
PLoS Pathog. 2021 Jan 25;17(1):e1009246. doi: 10.1371/journal.ppat.1009246. eCollection 2021 Jan.
8
SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.严重急性呼吸综合征冠状病毒2感染与心脏肿瘤学:从心脏代谢危险因素到癌症患者的预后
Cancers (Basel). 2020 Nov 10;12(11):3316. doi: 10.3390/cancers12113316.
9
A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2.一种天然食品防腐剂乳链菌肽(nisin)可以与人 SARS-CoV-2 刺突蛋白受体 ACE2 相互作用。
Virology. 2021 Jan 2;552:107-111. doi: 10.1016/j.virol.2020.10.002. Epub 2020 Oct 28.
10
Coronavirus biology and replication: implications for SARS-CoV-2.冠状病毒的生物学与复制:对 SARS-CoV-2 的启示。
Nat Rev Microbiol. 2021 Mar;19(3):155-170. doi: 10.1038/s41579-020-00468-6. Epub 2020 Oct 28.